Supreme Pharmaceuticals Inc. | Balance Sheet
Fiscal year is July-June. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
0.30
1,121.20
570.20
4,930.60
57,681.60
55,896
Total Accounts Receivable
0.60
58.90
42.50
331.70
1,055.20
8,467.80
Other Current Assets
-
60.60
474.50
235.20
1,042.10
1,289.80
Total Current Assets
0.80
1,240.80
1,087.20
5,497.40
59,778.90
73,516
Net Property, Plant & Equipment
-
4,785.50
8,934.00
10,274.90
26,638.90
101,524.50
Total Investments and Advances
22.50
22.50
-
115.00
1,088.60
16,346.60
Long-Term Note Receivable
-
50.00
-
-
-
-
Intangible Assets
-
-
8,396.90
8,396.90
8,396.90
8,396.90
Other Assets
280.20
8,666.40
16.70
-
-
-
Total Assets
303.50
14,765.30
18,434.90
24,284.30
95,903.30
199,784.10
ST Debt & Current Portion LT Debt
-
-
3,636.70
3,500.00
-
Accounts Payable
183.10
-
-
-
-
Other Current Liabilities
273.00
825.60
401.20
883.00
5,110.60
Total Current Liabilities
456.10
825.60
4,038.00
4,383.00
5,110.60
Long-Term Debt
-
3,513.30
809.60
536.70
38,408.80
Total Liabilities
456.10
4,338.90
4,847.50
4,919.70
43,519.50
Common Equity (Total)
152.60
10,426.40
13,587.40
19,364.60
52,383.90
Total Shareholders' Equity
152.60
10,426.40
13,587.40
19,364.60
52,383.90
Total Equity
152.60
10,426.40
13,587.40
19,364.60
52,383.90
Liabilities & Shareholders' Equity
303.50
14,765.30
18,434.90
24,284.30
95,903.30
About Supreme Pharmaceuticals
View Profile
